Eckert & Ziegler SE (XTER:EUZ) GF Score : 88/100 (As of Jun. 08, 2024)

View and export this data going back to 1999. Start your Free Trial

What is Eckert & Ziegler SE GF Score?

Eckert & Ziegler SE has the GF Score of 88, which implies that the company might have Good outperformance potential.

The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.

GF Score takes following five key aspects into consideration:

1. Financial Strength : 8/10
2. Profitability Rank : 9/10
3. Growth Rank : 6/10
4. GF Value Rank : 9/10
5. Momentum Rank : 7/10

Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.

Based on research and backtesting result, GuruFocus believes Eckert & Ziegler SE might have Good outperformance potential.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Eckert & Ziegler SE's GF Score

For the Medical Devices subindustry, Eckert & Ziegler SE's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eckert & Ziegler SE's GF Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Eckert & Ziegler SE's GF Score distribution charts can be found below:

* The bar in red indicates where Eckert & Ziegler SE's GF Score falls into.

Eckert & Ziegler SE (XTER:EUZ) GF Score Explanation

Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:

GF Score	Performance Potential and All-in-One Screener Examples ⁽¹⁾
91 - 100	Highest outperformance potential
81 - 90	Good outperformance potential
71 - 80	Likely to have average performance
51 - 70	Poor future performance potential
0 - 50	Worst future performance potential, or not enough data

(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.

Eckert & Ziegler SE GF Score Related Terms

Thank you for viewing the detailed overview of Eckert & Ziegler SE's GF Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Eckert & Ziegler SE (XTER:EUZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eckert & Ziegler SE (XTER:EUZ) » Definitions » GF Score

Comparable Companies

Traded in Other Exchanges

1EUZ:Italy 0NZY:UK

Address

Robert-Rossle-Street 10, Berlin, BB, DEU, D-13125

Website

https://www.ezag.com

Eckert & Ziegler Strahlen- und Medizintechnik AG is a provider of isotope technology for medical, scientific and industrial use. It is primarily engaged in the business activities of cancer therapy, industrial radiometry, and nuclear-medical imaging. The business segments of the group are Isotope products; Medical and Holding company. The company generates maximum revenue from Isotope products segment. Geographically, it derives a majority of revenue from Europe and also has a presence in North America, Asia-Pacific, and other regions.

Executives

Dr. Andreas Eckert	Supervisory Board
Frank Perschmann	Supervisory Board
Dr. Hakim Bouterfa	Board of Directors
Prof. Dr. Wolfgang Maennig	Supervisory Board
Dr. Harald Hasselmann	Board of Directors

Eckert & Ziegler SE (XTER:EUZ) Headlines

No Headlines